National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
USA
ARDM
Research Interest: Erythropoietin (EPO) is approved by FDA for
administration to chronic renal disease patients and cancer patients to
treat anemia, but my active area of research is to understand how EPO
affects non-hematopoietic physiological response. My specific research
interest is focussed on how EPO affects inflammation in the brain and
periphery and regulates metabolic homeostasis
Research Interest: Pharma/Medicine/Biology/Diseases
(Cardiac,Renal, Neuro), Drug development processes/Clinical &
Pre-Clinical trials, Herbal/Phyto-Chemical and Therapeutic Interventions
Biography: Dr. Ao Li has received his PhD in Peking Union Medical Collage during the period of 2008-2013. Currently, she is working as visiting associate professor in Yale University. He/ She has successfully completed his Administrative responsibilities as research scientist. She is serving as an editorial member of several reputed journals like Journal of Nephrology & Therapeutics she has authored 11research articles. He/she is a member of American Society of Nephrology.